Despite medium to large reductions in EDE-Q Restraint ( d = 1.21), Eating Concern ( d = 0.45), Shape Concern ( d = 0.99), and EDE-Q Global ( d = 0.82) scores, these pre- to post-treatment differences did not reach statistical significance.
← all excerpts
A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control.
1
—
—